Medifast
MED
258 hedge funds and large institutions have $1.69B invested in Medifast in 2018 Q2 according to their latest regulatory filings, with 58 funds opening new positions, 85 increasing their positions, 85 reducing their positions, and 23 closing their positions.
152% more first-time investments, than exits
New positions opened: 58 | Existing positions closed: 23
69% more capital invested
Capital invested by funds: $1,000M → $1.69B (+$691M)
29% more call options, than puts
Call options by funds: $25.7M | Put options by funds: $20M
15% more funds holding
Funds holding: 225 → 258 (+33)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0% more repeat investments, than reductions
Existing positions increased: 85 | Existing positions reduced: 85
1.18% less ownership
Funds ownership: 88.85% → 87.68% (-1.2%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$20.2M |
| 2 |
TA
Teachers Advisors
New York
|
+$16.2M |
| 3 |
Goldman Sachs
New York
|
+$9.84M |
| 4 |
IECM
Intrinsic Edge Capital Management
Chicago,
Illinois
|
+$7.36M |
| 5 |
MSE
MUFG Securities EMEA
London,
United Kingdom
|
+$6.71M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
-$33.7M |
| 2 |
MWNA
Marshall Wace North America
New York
|
-$15.4M |
| 3 |
JP Morgan Chase
New York
|
-$10.8M |
| 4 |
American Century Companies
Kansas City,
Missouri
|
-$9.45M |
| 5 |
Morgan Stanley
New York
|
-$8.95M |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
QT
276
Quantbot Technologies
New York
| – | -$3K | -38 | Closed |
|
|
APP
277
Avantax Planning Partners
Dubuque,
Iowa
| – | -$1K | -7 | Closed |
|
|
ML
278
McAdam LLC
Philadelphia,
Pennsylvania
| – | -$1K | -6 | Closed |
|
|
ADL
279
Asset Dedication LLC
San Francisco,
California
| – | +$128 | +1 | New |
|
|
BCA
280
Bay Colony Advisors
Concord,
Massachusetts
| – | +$256 | +2 | New |
|
281
Toronto Dominion Bank
Toronto, Ontario,
Ontario, Canada
| – | +$384 | +3 | New |
|
MED Hedge Fund Activity: Q2 2018 in Review
258 of the 4,369 institutional investors tracked by Wall St. Rank reported a position in Medifast (MED) for Q2 2018, worth a combined $1.69B — up 69% from $1,000M a quarter earlier.
Buyers outnumbered sellers: 58 funds opened new MED positions and 23 closed out — a net gain of 35 holders — while 85 added to existing stakes and 85 trimmed.
The largest buyer was Vanguard Group, adding an estimated $20.2M. The largest seller was Millennium Management, cutting an estimated $33.7M.
- 258 institutional investors held Medifast (MED) as of Q2 2018, up from 225 in Q1 2018.
- Funds reported $1.69B of Medifast stock for Q2 2018, up 69% quarter-over-quarter.
- 58 funds opened new Medifast positions in Q2 2018 and 23 closed out, a net change of +35 holders.
- The largest Medifast buyer in Q2 2018 was Vanguard Group, an estimated $20.2M added.
- The largest Medifast seller in Q2 2018 was Millennium Management, an estimated $33.7M sold.
Based on aggregated 13F filings for Q2 2018.